CXCL8 and type 1 diabetes mellitus: Improvements in markers for risk for cardiovascular disease (low-density lipoprotein [LDL]- and high-density lipoprotein [HDL]- cholesterol levels) in patients with T1D were associated with a reduction in LPS-induced secretion of CXCL8 from monocytes (122).